HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Failure of repeated courses of high-dose intravenous immunoglobulin to induce stable remission in patients with chronic idiopathic thrombocytopenic purpura.

Abstract
Repeated courses of HD IVIg are reported to induce stable remission in a significant proportion of adults with chronic refractory ITP. We have treated 14 such patients obtaining a remission rate quite comparable to the 5-10% of spontaneous remission.
AuthorsC Schiavotto, M Ruggeri, F Rodeghiero
JournalAnnals of hematology (Ann Hematol) Vol. 70 Issue 2 Pg. 89-90 (Feb 1995) ISSN: 0939-5555 [Print] Germany
PMID7880930 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Immunoglobulins, Intravenous
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulins, Intravenous (standards, therapeutic use)
  • Male
  • Middle Aged
  • Purpura, Thrombocytopenic, Idiopathic (blood, drug therapy)
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: